CogMe Overview
CogMe aims to improve health outcomes by reducing cognitive and physiological deterioration in older adults at risk. Using AI, CogMe provides a holistic solution that analyzes cognitive, physiological and activity indicators of the individual patient to predict, detect and intervene to prevent decline in inpatient and outpatient settings. Addressing a multi-billion unmet market need, the solution is an expert system that applies clinical guidelines and know-how, enhanced with machine and deep learning methodologies, to provide actionable data for personalized care plans initially focusing on delirium.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
MindUP Invests in its 13th Portfolio Company: CogMe, a Holistic Solution to Detect and Prevent Delirium
MindUP, Israels digital health incubator, has welcomed CogMe to its portfolio companies. CogMe is developing a platform to reduce cognitive drops in populations at risk, starting with delirium. Using AI, CogMe will analyze cognitive and biological indicators to predict, detect, and intervene to prevent cognitive drops. MindUP sees CogMe as providing a scalable and sustainable solution for healthcare providers to predict and prevent cognitive drops. MindUP is a joint venture of Medtronic, IBM, Pitango Venture Capital, Impact First Investments, and Rambam Medical Center.
PartnersCustomers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $1.4M |
| Last funding | $1.4M |
| Stage | Seed |
| Rounds | 1 |
| Investors | 4 |
Team Members
3
Employees: 1-10
Web & Social Links
Locations
Netiv HaOr 1, Haifa, Israel
Photos & Videos
No files yet
